AI-Driven Multimodal Imaging Integration for Diagnosis and Prognostication of Digestive System Diseases
Recruiting now
Conditions studied: Digestive Diseases, Radiology, AI (Artificial Intelligence), Imaging
In brief
The goal of this observational, retrospective and prospective study is to develop a noninvasive disease assessment system by leveraging artificial intelligence (AI) to comprehensively analyze multi-modal imaging features, including magnetic resonance enterography (MRE) and computed tomography enterography (CTE), for the diagnosis and prognostication of digestive diseases. To this end, the investigators retrospectively enrolled imaging, endoscopic, and clinical data from 21 centers across China to construct and iteratively optimize the AI model. The model's performance will be prospectively validated in two centers, and its accuracy in lesion localization will be verified through real-world deployment in endoscopy suites.
Key facts
- Study ID
- NCT07087418
- Run by
- First Affiliated Hospital, Sun Yat-Sen University
- People needed
- 5000
- Starts
- 2025-07-01
- Expected to finish
- 2026-08-01
- Last updated by the study team
- 2026-04-13
Who can join
Age: any. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Patients with multimodal-confirmed diagnoses (clinical, imaging, endoscopic, and pathological) of:
- Inflammatory bowel disease (IBD; Crohn's disease or ulcerative colitis)
- Intestinal tuberculosis
- Behçet's disease
- Availability of ≥1 technically adequate CT or MR scan with high-quality colonoscopy performed within ±1 month of imaging.
You may not qualify if…
- ・Suboptimal imaging quality (e.g., low-dose artifacts, metal artifacts)
- Inadequate bowel preparation for endoscopy
- Incomplete examinations due to poor tolerance
Where it is running
- XploreMET v3.0 system — Shanghai, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.